✦ LIBER ✦

777 Poster Hyperfractionated radiotherapy in treatment of locally advanced head & neck cancer — 3-years results and evaluation of tolerance

Book ID: 119513422
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 143 KB
Volume: 64
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(02)83086-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five year results of a randomized trial

Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer

✍ Bernard Cummings; Thomas Keane; Melania Pintilie; Padraig Warde; John Waldron; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Concurrent radiotherapy and chemotherapy

Concurrent radiotherapy and chemotherapy in the treatment of locally advanced head and neck cancer

✍ G. Arcangeli; B. Saracino; D. Tirindelli Danesi; G. Giovinazzo; F. Cognetti; P. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Intravenous delivery of 5′-iododeoxyurid

Intravenous delivery of 5′-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: Results of a pilot study

✍ Alan H. Epstein; Robert S. Lebovics; Carter Van Waes; Judy Smith; Paul Okunieff; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

691 poster Local hyperthermia in the tre

691 poster Local hyperthermia in the treatment of advanced head and neck cancer

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Radiochemotherapy in the treatment of lo

Radiochemotherapy in the treatment of locally advanced head and neck cancer: results after five years of a randomized study

✍ M. Santarelli; N. Raffetto; P. Torcia; V. De Santis; V. Donato; R.Maurizi Enrici 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which